Bromocriptine, a Dopamine (d2) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub-Therapeutic Doses to Ameliorate Hyperglycaemia. [electronic resource]
By: Contributor(s): Producer: 20131101Description: 1904-7 p. digitalISSN:- 2249-782X
Publication Type: Journal Article
There are no comments on this title.
-
1
Anxiety and psychosocial stress as predictors of headache and abdominal pain in urban early adolescents.
by White, Kamila S -
2
Individual and contextual factors associated with patterns of aggression and peer victimization during middle school.
by Bettencourt, Amie F -
3
Longitudinal relations between trauma-related psychological distress and physical aggression among urban early adolescents.
by Thompson, Erin L -
4
Evaluation of the Computerized Assessment System for Psychotherapy Evaluation and Research (CASPER) interview with a psychiatric inpatient population.
by Strong, Joanna E -
5
The study designed by a committee: design of the Multisite Violence Prevention Project.
by Henry, David B -
6
The Promotive and Protective Effects of Family Factors in the Context of Peer and Community Risks for Aggression.
by Kramer-Kuhn, Alison M -
7
Stability and change in patterns of peer victimization and aggression during adolescence.
by Bettencourt, Amie -
8
Methodological challenges examining subgroup differences: examples from universal school-based youth violence prevention trials.
by Farrell, Albert D -
9
Peer victimization in early adolescence: association between physical and relational victimization and drug use, aggression, and delinquent behaviors among urban middle school students.
by Sullivan, Terri N -
10
Dating violence perpetration and perceived parental support for fighting and nonviolent responses to conflict: An autoregressive cross-lagged model.
by Garthe, Rachel C -
11
Beliefs about Fighting and Their Relations to Urban Adolescents' Frequency of Aggression and Victimization: Evaluation of the Beliefs about Fighting Scale.
by Farrell, Albert D -
12
Relation between witnessing violence and drug use initiation among rural adolescents: parental monitoring and family support as protective factors.
by Sullivan, Terri N -
13
Longitudinal relationships between individual and class norms supporting dating violence and perpetration of dating violence.
by Taylor, Katherine A -
14
Dimensions of Peer Influences and Their Relationship to Adolescents' Aggression, Other Problem Behaviors and Prosocial Behavior.
by Farrell, Albert D -
15
Correction to: Dimensions of Peer Influences and Their Relationship to Adolescents' Aggression, Other Problem Behaviors and Prosocial Behavior.
by Farrell, Albert D -
16
Designs for Evaluating the Community-Level Impact of Comprehensive Prevention Programs: Examples from the CDC Centers of Excellence in Youth Violence Prevention.
by Farrell, Albert D -
17
Patterns of Change in Adolescent Dating Victimization and Aggression During Middle School.
by Goncy, Elizabeth A -
18
Deviant Peer Factors During Early Adolescence: Cause or Consequence of Physical Aggression?
by Thompson, Erin L -
19
Evaluation of the Computerized Assessment System for Psychotherapy Evaluation and Research (CASPER) as a measure of treatment effectiveness with psychiatric inpatients.
by Kinnaman, Joanna E Strong -
20
Using surveillance data to inform community action: the effect of alcohol sale restrictions on intentional injury-related ambulance pickups.
by Masho, Saba W
Bromocriptine, a Dopamine (d2) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub-Therapeutic Doses to Ameliorate Hyperglycaemia.
APA
Kumar V S H., M B V., A N P., Aithal S., Baleed S. R. & Patil U. N. (20131101). Bromocriptine, a Dopamine (d2) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub-Therapeutic Doses to Ameliorate Hyperglycaemia. : Journal of clinical and diagnostic research : JCDR.
Chicago
Kumar V S Harish, M B Vinutha, A N Pradeep, Aithal Sathisha, Baleed Sindhura Reddy and Patil Umakant N. 20131101. Bromocriptine, a Dopamine (d2) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub-Therapeutic Doses to Ameliorate Hyperglycaemia. : Journal of clinical and diagnostic research : JCDR.
Harvard
Kumar V S H., M B V., A N P., Aithal S., Baleed S. R. and Patil U. N. (20131101). Bromocriptine, a Dopamine (d2) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub-Therapeutic Doses to Ameliorate Hyperglycaemia. : Journal of clinical and diagnostic research : JCDR.
MLA
Kumar V S Harish, M B Vinutha, A N Pradeep, Aithal Sathisha, Baleed Sindhura Reddy and Patil Umakant N. Bromocriptine, a Dopamine (d2) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub-Therapeutic Doses to Ameliorate Hyperglycaemia. : Journal of clinical and diagnostic research : JCDR. 20131101.